UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2038-2045

2009

Volltextzugriff (PDF)

Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice

BMC pulmonary medicine, 2022-08, Vol.22 (1), p.1-325, Article 325

2022

Volltextzugriff (PDF)

Treatment of haemothorax

Respiratory medicine, 2010-11, Vol.104 (11), p.1583-1587

2010

Volltextzugriff (PDF)

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study

Journal of clinical oncology, 2011-11, Vol.29 (32), p.4320-4326

2011

Volltextzugriff (PDF)

Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations

The European journal of health economics, 2020-08, Vol.21 (6), p.931-943

2020

Volltextzugriff (PDF)

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001865

2021

Volltextzugriff (PDF)

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7974-7984

2005

Volltextzugriff (PDF)

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Journal of thoracic oncology, 2023-02, Vol.18 (2), p.181-193

2023

Volltextzugriff (PDF)

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005581

2022

Volltextzugriff (PDF)

Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis

Lung cancer (Amsterdam, Netherlands), 2015-09, Vol.89 (3), p.255-261

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Adding Granulocyte Colony-Stimulating Factor to Primary Prophylaxis With Antibiotics in Small-Cell Lung Cancer

Journal of clinical oncology, 2006-07, Vol.24 (19), p.2991-2997

2006

Volltextzugriff (PDF)

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

Frontiers in oncology, 2020-06, Vol.10, p.890-890

2020

Volltextzugriff (PDF)

Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review

The Annals of thoracic surgery, 2022-09, Vol.114 (3), p.1064-1071

2022

Volltextzugriff (PDF)

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer

Frontiers in digital health, 2023, Vol.5, p.1303261-1303261

2023

Volltextzugriff (PDF)

Lung Cancer in the Netherlands

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.355-365

2021

Volltextzugriff (PDF)

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

British journal of cancer, 2019-08, Vol.121 (5), p.372-377

2019

Volltextzugriff (PDF)

Prevalence of Birt-Hogg-Dubé syndrome in patients with apparently primary spontaneous pneumothorax

The European respiratory journal, 2015-04, Vol.45 (4), p.1191-1194

2015

Volltextzugriff (PDF)

Pneumonectomy for Lung Cancer Treatment in The Netherlands: Between-Hospital Variation and Outcomes

World journal of surgery, 2020, Vol.44 (1), p.285-294

2020

Volltextzugriff (PDF)

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.249-254

2015

Volltextzugriff (PDF)

Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment

Journal of thoracic disease, 2018-10, Vol.10 (Suppl 29), p.S3472-S3485

2018

Volltextzugriff (PDF)

Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

Lung cancer (Amsterdam, Netherlands), 2024-10, Vol.196, p.107950, Article 107950

2024

Volltextzugriff (PDF)

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221116605-17588359221116605

2022

Volltextzugriff (PDF)

Post-mortem findings in 22 fatal Taxus baccata intoxications and a possible solution to its detection

Journal of forensic and legal medicine, 2017-11, Vol.52, p.56-61

2017

Volltextzugriff (PDF)

Fatal necrotizing pancreatitis during combined treatment with erlotinib and sunitinib

Lung cancer (Amsterdam, Netherlands), 2010-12, Vol.70 (3), p.364-365

2010

Volltextzugriff (PDF)

Lung Density Measurements in Spontaneous Pneumothorax Demonstrate Airtrapping

Chest, 2004-06, Vol.125 (6), p.2083-2090

2004

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(343)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice

Treatment of haemothorax

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study

Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis

Cost-Effectiveness of Adding Granulocyte Colony-Stimulating Factor to Primary Prophylaxis With Antibiotics in Small-Cell Lung Cancer

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer

Lung Cancer in the Netherlands

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

Prevalence of Birt-Hogg-Dubé syndrome in patients with apparently primary spontaneous pneumothorax

Pneumonectomy for Lung Cancer Treatment in The Netherlands: Between-Hospital Variation and Outcomes

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment

Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC

Post-mortem findings in 22 fatal Taxus baccata intoxications and a possible solution to its detection

Fatal necrotizing pancreatitis during combined treatment with erlotinib and sunitinib

Lung Density Measurements in Spontaneous Pneumothorax Demonstrate Airtrapping

Suchergebnisse filtern